[go: up one dir, main page]

PE20030696A1 - Brivudina estabilizada en formulaciones topicas - Google Patents

Brivudina estabilizada en formulaciones topicas

Info

Publication number
PE20030696A1
PE20030696A1 PE2002001227A PE2002001227A PE20030696A1 PE 20030696 A1 PE20030696 A1 PE 20030696A1 PE 2002001227 A PE2002001227 A PE 2002001227A PE 2002001227 A PE2002001227 A PE 2002001227A PE 20030696 A1 PE20030696 A1 PE 20030696A1
Authority
PE
Peru
Prior art keywords
brivudine
hydroxy
sulphonate
naphthalin
diphenyl
Prior art date
Application number
PE2002001227A
Other languages
English (en)
Inventor
Christian Schnittker
Sigrid Keipert
Karsten Groger
Reinhard Schmitz
Carlo Alberto Maggi
Stefano Manzini
Original Assignee
Menarini Ricerche Spa
Berlin Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Spa, Berlin Chemie Ag filed Critical Menarini Ricerche Spa
Publication of PE20030696A1 publication Critical patent/PE20030696A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Devices For Dispensing Beverages (AREA)
  • Filling Of Jars Or Cans And Processes For Cleaning And Sealing Jars (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA PARA USO TOPICO QUE CONTIENE (E)-5-(2-BROMOVINIL)-2'-DEOXIURIDINA (BRIVUDINA); DE 0,1% A 10% p/p DE UN FOTOSENSIBILIZADOR SELECCIONADO DE CAROTENOIDES Y DERIVADOS DE O-HIDROXI-BENZOFENONA (DIOXIBENZONA, OXIBENZONA, 2,2',4,4'-TETRAHIDROXIBENZOFENONA, SULISOBENZONA, 2,4-DIHIDROXI BENZOFENONA, SULFONATO DE 2,2'-DIHIDROXI-4-4'-DIMETOXIBENZOFENONA-5,5'DISODIO), CANFOR, CINAMATO, DIFENIL-PROPAN-1,3-DIONA, ACIDO CIANO-DIFENIL-ACRILICO, FENIL-AZO-BENCENO (7-HIDROXI-8-(4-SULFONATO-1-NAFTILAZO)-NAFTALIN-1,3-DISULFONICO, ACIDO (2,4-DIHIDROXIAZOBENZO)-4'-SULFONICO, ACIDO 3-HIDROXI-4-(4-SULFONATO-1-NAFTILAZO)-NAFTALIN-2,7-DISULFONICO JUNTO CON EXCIPIENTES. UNA COMPOSICION PREFERIDA ES 1% BRIVUDINA, 4% OXIBENZONA, 29,5% MIRISTATO DE ISOPROPILO; 11,8% POLOXAMERO 101, 17,7% POLISORBATO 85; 10,7% DIOXIDO DE SILICIO, UN PRESERVADOR ANTIMICROBIANO LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO TOPICO DE INFECCIONES POR VIRUS DE VARICELA ZOSTER, VIRUS DE HERPES SIMPLEX TIPO 1
PE2002001227A 2001-12-19 2002-12-13 Brivudina estabilizada en formulaciones topicas PE20030696A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10162593A DE10162593A1 (de) 2001-12-19 2001-12-19 Stabilisierte topische Brivudin-Formulierungen

Publications (1)

Publication Number Publication Date
PE20030696A1 true PE20030696A1 (es) 2003-09-22

Family

ID=7709921

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002001227A PE20030696A1 (es) 2001-12-19 2002-12-13 Brivudina estabilizada en formulaciones topicas

Country Status (15)

Country Link
US (1) US20040259835A1 (es)
EP (1) EP1463513B1 (es)
JP (1) JP2005516929A (es)
CN (1) CN1316977C (es)
AR (1) AR038455A1 (es)
AU (1) AU2002366273A1 (es)
CA (1) CA2470629A1 (es)
DE (2) DE10162593A1 (es)
ES (1) ES2280625T3 (es)
PA (1) PA8562001A1 (es)
PE (1) PE20030696A1 (es)
PL (1) PL369581A1 (es)
RU (1) RU2306935C2 (es)
UY (1) UY27591A1 (es)
WO (1) WO2003051375A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
TWI334788B (en) * 2004-01-06 2010-12-21 Shiseido Co Ltd Single phase microemulsion composition, oil in water (o/w) supermicro emulsion external agent, and manufacturing method therefor
DE102005046769A1 (de) * 2005-09-29 2007-04-05 Berlin-Chemie Ag Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
PT1962808E (pt) * 2005-12-14 2010-10-29 Hoffmann La Roche Formulação de precursor de fármaco para o hcv
CN101516367A (zh) * 2006-09-15 2009-08-26 安斯泰来制药有限公司 对光稳定的雷莫司琼的固态医药组合物
US20100323998A1 (en) * 2007-08-06 2010-12-23 Glenmark Pharmaceuticals Ltd. Topical composition containing the combination of mupirocin and beclomethasone
EP2303227B1 (en) 2008-05-14 2021-10-06 Otonomy, Inc. Controlled release corticosteroid compositions and methods for the treatment of otic disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
SG175327A1 (en) * 2009-04-22 2011-11-28 Agency Science Tech & Res Emulsions for transdermal delivery
US8741953B2 (en) * 2009-09-22 2014-06-03 Vlife Sciences Technologies Pvt. Ltd. Topical formulation for diabetic foot ulcers
EP2490722A4 (en) * 2009-10-21 2014-03-05 Otonomy Inc MODULATION OF THE TEMPERATURE OF GELIFICATION OF FORMULATIONS CONTAINING POLOXAMERS
WO2013123658A1 (en) 2012-02-23 2013-08-29 Empire Technology Development Llc Azobenzene compounds with cholesterol group and their sunscreen compositions
AU2014311358A1 (en) 2013-08-27 2016-04-07 Otonomy, Inc. Treatment of pediatric otic disorders
CN106138018B (zh) 2015-04-02 2020-03-13 广州洁成生物科技有限公司 羟基二苯甲酮在制备抗病毒和抗肿瘤药物中的应用
ES2807226T3 (es) * 2016-08-31 2021-02-22 Chr Hansen Natural Colors As Composición colorante dispersable en agua
CN113712928A (zh) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 经口腔粘膜吸收的溴夫定药物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
RU2133120C1 (ru) * 1995-12-14 1999-07-20 Сантр Энтернасьональ де Решерш Дерматоложик Галдерма Косметическая или дерматологическая композиция типа эмульсии вода-в-масле
CZ284920B6 (cs) * 1996-02-14 1999-04-14 Vladimír Prof. Mudr. Drsc. Vonka Preparáty pro léčbu rekurentního herpesu založené na potenciaci účinků syntetických virostatik kofeinem
GB9618974D0 (en) * 1996-09-11 1996-10-23 Glaxo Group Ltd Medicaments
DE19956601A1 (de) * 1999-11-25 2001-05-31 Cognis Deutschland Gmbh Kosmetische und/oder pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
ES2280625T3 (es) 2007-09-16
PA8562001A1 (es) 2003-07-28
DE10162593A1 (de) 2003-07-03
EP1463513A1 (en) 2004-10-06
RU2004118426A (ru) 2005-04-20
RU2306935C2 (ru) 2007-09-27
AR038455A1 (es) 2005-01-19
CA2470629A1 (en) 2003-06-26
DE60218346T2 (de) 2007-11-08
DE60218346D1 (de) 2007-04-05
AU2002366273A1 (en) 2003-06-30
EP1463513B1 (en) 2007-02-21
JP2005516929A (ja) 2005-06-09
CN1604782A (zh) 2005-04-06
CN1316977C (zh) 2007-05-23
US20040259835A1 (en) 2004-12-23
UY27591A1 (es) 2003-02-28
PL369581A1 (en) 2005-05-02
WO2003051375A1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
PE20030696A1 (es) Brivudina estabilizada en formulaciones topicas
ES2138969T3 (es) Combinacion de nucleosidos antivirales.
ATE131730T1 (de) Nukleosidanalogen enthaltende antiviren- zubereitungen
ITMI20021392A1 (it) Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
YU7296A (sh) Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida
IT1248702B (it) Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche
DK0656774T3 (da) Kosmetiske og dermatologiske lysbeskyttelsesformuleringer med et indhold af thioler og/eller thiolderivater
ATE76748T1 (de) Arzneimittel fuer den bereich der mundhoehle.
PA8483101A1 (es) Compuestos quimicos
UY26383A1 (es) "compuestos farmacéuticamente activos"
ES2137260T3 (es) Composicion farmaceutica para uso en el tratamiento del glaucoma.
DE69906084D1 (de) Ibuprofen enthaltende schnelllösliche zusammensetzungen mit analgetischer wirkung
KR970705978A (ko) 가역성열겔화 수용성 의약 조성물을 함유하는 동결건조 제제(Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation)
BR9809571A (pt) Composição medicinal e processo para produzì-la
GT199900129A (es) Formulaciones liquidas de pirimetanilo y metodos para su preparacion.
FI955403A0 (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
IS2860B (is) Veirueyðandi samsetningar
DE69221150D1 (de) Pharmakologisch verbesserte formulierungen
FI913034A0 (fi) Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning.
BR0308874A (pt) Composição aquosa injetável, método para produzir a mesma, e, uso de copolìmeros em bloco polioxipropileno/polioxietileno
WO1991015200A3 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
BR9714279A (pt) Preparação aquosa, e, uso da mesma.
BR0108727A (pt) Composição micelar para o tratamento de doenças parasìticas em animais, e, uso de uma composição
ES2128353T3 (es) Composicion topica que contiene penciclovir.
TR199900013T2 (xx) Yeni bile�ikler.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal